Age-associated increase of prostate-specific antigen in a high level of men visiting urological clinics

International Journal of Urology

Volumn 12, Issue 8, 2005, Pages 733-738

  Kobayashi, Takashi ^a,b   Kinoshita, Hidefumi ^b   Nishizawa, Koji ^a   Mitsumori, Kenji ^a   Ogawa, Osamu ^b   Kamoto, Toshiyuki ^b  

^a HAMAMATSU ROSAI HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Age adjusted reference; Prostate specific antigen; Prostate specific antigen 1 antichymotrypsin; Urological patients

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AGING; ANAMNESIS; ARTICLE; CANCER SCREENING; CLINICAL PRACTICE; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SURGERY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALPHA 1-ANTICHYMOTRYPSIN; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OUTPATIENTS; PROSTATE-SPECIFIC ANTIGEN; REFERENCE VALUES; UROLOGIC DISEASES;

EID: 28544446425     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2005.01121.x     Document Type: Article

References (15)

1. Oesterling JE, Jacobsen SJ, Chute CG et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993; 270: 860-64.
2. Berger AP, Cheli C, Levine R, Klocker H, Bartsch G, Horninger W. Impact of age on complexed PSA levels in men with total PSA levels of up to 20 ng/mL. Urology 2003; 62: 840-44.
3. Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem. 1990; 194: 755-63.
4. Lilja H, Christensson A, Dahlen U et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin. Chem. 1991; 37: 1618-25.
5. Saika T, Tsushima T, Nasu Y et al. Prostate specific antigen complexed to alpha-1-antichymotrypsin in patients with intermediate prostate specific antigen levels. Cancer 2002; 94: 1685-91.
6. Kobayashi T, Kamoto T, Isogawa Y et al. Ratio of prostate specific antigen minor molecular forms-to-total prostate specific antigen is constant regardless of the pathological condition of the prostate. J. Urol. 2003; 169: 121-4.
7. Lein M, Jung K, Hammerer P et al. A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis. Prostate 2001; 47: 77-84.
8. Kuriyama M, Abrahamsson PA, Imai K et al. Determination of serum prostate-specific antigen-alpha1-antichymotrypsin complex for diagnosis of prostate cancer in Japanese cases. Scand. J. Urol. Nephrol. 2001; 35: 5-10.
9. Stamey TA. Second Stanford conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994. Urology 1995; 45: 173-84.
10. Kuriyama M, Uno H, Ueno K, Hamamoto Y, Vihn PQ, Ban Y. Comparative study of assays for prostate-specific antigen molecular forms. Jpn. J. Clin. Oncol. 1999; 29: 303-7.
11. Oesterling JE, Kumamoto Y, Tsukamoto T et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br. J. Urol. 1995; 75: 347-53.
12. Takahashi C, Miyagawa I. Serum prostate-specific antigen in a urological outpatient clinic. Efficacy of age-specific and prostate volume-specific reference range in detection of prostate cancer. Nippon Hinyokika Gakkai Zasshi 1997; 88: 612-17.
13. Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, McLeod DG, Moul JW. Age-specific reference ranges for prostate-specific antigen in black men. N. Engl. J. Med. 1996; 335: 304-10.
14. Ito K, Yamamoto T, Kubota Y et al. Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer. Urology 2000; 56: 278-82.
15. Okegawa T, Noda H, Nutahara K, Higashihara E. Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL. Urology 2000; 55: 700-704.